EDP-235
EDP 235-002
Phase 2 small_molecule completed
Quick answer
EDP-235 for COVID-19 is a Phase 2 program (small_molecule) at ENANTA PHARMACEUTICALS INC with 3 ClinicalTrials.gov record(s).
Program details
- Company
- ENANTA PHARMACEUTICALS INC
- Indication
- COVID-19
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed